15-hydroxy 6,9-hemiacetal erythromycin compounds
AssigneeTakeda Chemical
InventorsSetsuo Harada, Yasunori Funabashi, Nobuhiro Inatomi, Shigeharu Tanayama, Seiichi Tanida
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Chemical
InventorsSetsuo Harada, Yasunori Funabashi, Nobuhiro Inatomi, Shigeharu Tanayama, Seiichi Tanida
Estimating the term…
Disclosed are (1) a structurally novel 6,9-hemiacetal- erythromycin derivative having a hydroxyl group at at least one of the 14- and 15-positions br a salt thereof, which has an excellent gastrointestinal function promoting effect and is low in toxicity; (2) a process for preparing a 6,9-hemiacetal-erythromycin derivative having a hydroxyl group at at least one of the 14- and 15-positions or a salt thereof, which comprises reacting a 6,9-hemiacetal-erythromycin derivative or a salt thereof with an organism-derived oxidase; and (3) a gastrointestinal function promoting agent containing a 6,9-hemiacetal-erythromycin derivative having a hydroxyl group at at least one of the 14- and 15-positions or a salt thereof.
A 6,9-hemiacetal-erythromycin compound having a hydroxyl group at the 15-position or a salt thereof.
A process for preparing a 6-9-hemiacetal-erythromycin compound having a hydroxyl group at the 15-position or a salt thereof, which comprises reacting a 6,9-hemiacetal-erythromycin compound or a salt thereof with an oxidase derived from an actinomycete or from a liver of a mammal.
A process for preparing the 6,9-hemiacetal-erythromycin compound represented by the formula (16):
A process for preparing the 6,9-hemiacetal-erythromycin compound represented by the formula (18):
Dependencies are inferred from the claim text.